{"id":20856,"date":"2021-05-31T22:57:38","date_gmt":"2021-05-31T22:57:38","guid":{"rendered":"https:\/\/evaggelatos.com\/?p=20856"},"modified":"2021-05-31T23:03:43","modified_gmt":"2021-05-31T23:03:43","slug":"%ce%bc%ce%b1%cf%82-%ce%ba%ce%bf%cf%81%ce%bf%cf%8a%ce%b4%ce%b5%cf%8d%ce%bf%cf%85%ce%bd-%ce%be%ce%b5%ce%b4%ce%b9%ce%ac%ce%bd%cf%84%cf%81%ce%bf%cf%80%ce%b1-%ce%bf%ce%b9-%ce%ba%ce%b5%cf%81%ce%b4%ce%bf","status":"publish","type":"post","link":"https:\/\/evaggelatos.com\/?p=20856","title":{"rendered":"\u039c\u03b1\u03c2 \u03ba\u03bf\u03c1\u03bf\u03ca\u03b4\u03b5\u03cd\u03bf\u03c5\u03bd \u03be\u03b5\u03b4\u03b9\u03ac\u03bd\u03c4\u03c1\u03bf\u03c0\u03b1 \u03bf\u03b9 \u03ba\u03b5\u03c1\u03b4\u03bf\u03c3\u03ba\u03cc\u03c0\u03bf\u03b9 \u03c4\u03b7\u03c2 \u03a5\u03b3\u03b5\u03af\u03b1\u03c2 \u03bc\u03b1\u03c2: \u03a4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 COVID-19 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03bc\u03cc\u03bd\u03bf \u03c3\u03c4\u03bf 0,84%, \u03b4\u03b7\u03bb\u03b1\u03b4\u03ae \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf 1%, \u03ba\u03b1\u03b9 \u03b4\u03b5\u03bd \u03b1\u03bd\u03c4\u03b1\u03c0\u03bf\u03ba\u03c1\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1."},"content":{"rendered":"<h1 class=\"post-title\">\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c3\u03c4\u03bf THE LANCET \u03c4\u03b7\u03c2 \u0394\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5\u03c2\u00a0 \u03ba\u03b1\u03b9 \u03b4\u03ae\u03b8\u03b5\u03bd \u0391\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u0395\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd Covid-19<\/h1>\n<div class=\"kpm la1\"><\/div>\n<p class=\"post-byline\"><a title=\"\u0386\u03c1\u03b8\u03c1\u03b1 \u03c4\u03bf\u03c5\/\u03c4\u03b7\u03c2 \u039d\u03af\u03ba\u03bf\u03c2 \u03a7\u03b5\u03b9\u03bb\u03b1\u03b4\u03ac\u03ba\u03b7\u03c2\" href=\"http:\/\/nikosxeiladakis.gr\/author\/nxeiladak\/\" rel=\"author\">\u039d\u03af\u03ba\u03bf\u03c2 \u03a7\u03b5\u03b9\u03bb\u03b1\u03b4\u03ac\u03ba\u03b7\u03c2<\/a> \u00b7 31 \u039c\u03b1\u0390\u03bf\u03c5 2021<\/p>\n<p>&#8230;.\u0388\u03bd\u03b1 \u03b1\u03c0\u03cc \u03c4\u03b1 \u03c0\u03bb\u03ad\u03bf\u03bd \u03b4\u03b9\u03ac\u03c3\u03b7\u03bc\u03b1 \u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ac \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ac \u03c3\u03c4\u03bf\u03bd \u03ba\u03cc\u03c3\u03bc\u03bf, \u03c4\u03bf The<br \/>\nLancet, \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03bc\u03b9\u03b1 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c0\u03bf\u03c5 \u03b4\u03b5\u03af\u03c7\u03bd\u03b5\u03b9 \u03cc\u03c4\u03b9 <strong>\u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 COVID-19 \u03b5\u03af\u03bd\u03b1\u03b9<\/strong><br \/>\n<strong>\u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03bc\u03cc\u03bd\u03bf \u03c3\u03c4\u03bf 0,84%, \u03b4\u03b7\u03bb\u03b1\u03b4\u03ae \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf 1%, \u03ba\u03b1\u03b9 \u03b4\u03b5\u03bd<\/strong><br \/>\n<strong>\u03b1\u03bd\u03c4\u03b1\u03c0\u03bf\u03ba\u03c1\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1.<\/strong><br \/>\n<strong>\u0391\u03c0\u03bf\u03b4\u03b5\u03b9\u03ba\u03bd\u03cd\u03b5\u03c4\u03b1\u03b9 \u03b7 -\u03b5\u03c0\u03af \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03cc\u03bd\u03c4\u03bf\u03c2- \u03c0\u03bb\u03ae\u03c1\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03c5\u03c7\u03af\u03b1! \u0391\u03c0\u03bf\u03ba\u03b1\u03bb\u03cd\u03c6\u03b8\u03b7\u03ba\u03b5 \u03b7<\/strong><br \/>\n<strong>\u03c0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03c0\u03b1\u03c1\u03b1\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03ac\u03c4\u03c9\u03bd \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2.<\/strong><\/p>\n<p>Pfizer-BioNTech (-95% \u03c4\u03b7\u03c2 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1\u03c2 \u03b1\u03c0\u03cc\u03b4\u03bf\u03c3\u03b7\u03c2)<\/p>\n<p>Moderna\u2013NIH \u00a0(-94% \u03c4\u03b7\u03c2 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1\u03c2 \u03b1\u03c0\u03cc\u03b4\u03bf\u03c3\u03b7\u03c2)<\/p>\n<p>SPUTNIK-V \u2013 Gamaleya (-90% \u03c4\u03b7\u03c2 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1\u03c2 \u03b1\u03c0\u03cc\u03b4\u03bf\u03c3\u03b7\u03c2)<\/p>\n<p>AstraZeneca -Oxford (-67% \u03c4\u03b7\u03c2 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1\u03c2 \u03b1\u03c0\u03cc\u03b4\u03bf\u03c3\u03b7\u03c2)<\/p>\n<p>J&amp;J (-67% \u03c4\u03b7\u03c2 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1\u03c2 \u03b1\u03c0\u03cc\u03b4\u03bf\u03c3\u03b7\u03c2)<\/p>\n<p>\u039a\u03b1\u03b9 \u03ac\u03bb\u03bb\u03b1 (96 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03c3\u03c5\u03bd\u03bf\u03bb\u03b9\u03ba\u03ac)&#8230;&#8230;.&gt;&gt;<\/p>\n<div class=\"yj6qo\">\n<h3><strong>\u0394\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u00a0\u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 COVID-19 COVID-19 \u2014 \u03bf \u03b5\u03bb\u03ad\u03c6\u03b1\u03bd\u03c4\u03b1\u03c2 \u00a0(\u03c0\u03bf\u03c5 \u03b4\u03b5\u03bd \u03b5\u03af\u03bd\u03b1\u03b9) \u03c3\u03c4\u03bf \u03b4\u03c9\u03bc\u03ac\u03c4\u03b9\u03bf \u00a0<\/strong><\/h3>\n<p>\u03a0\u03b5\u03c1\u03af\u03c0\u03bf\u03c5 96 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 COVID-19 \u03b2\u03c1\u03af\u03c3\u03ba\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b1 \u03c3\u03c4\u03ac\u03b4\u03b9\u03b1 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae\u03c2 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7\u03c2<sup>1<\/sup>. \u0395\u03c0\u03af \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03cc\u03bd\u03c4\u03bf\u03c2, \u03ad\u03c7\u03bf\u03c5\u03bc\u03b5 \u03c4\u03b1 \u00a0\u03b5\u03bd\u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b5\u03c3\u03c3\u03ac\u03c1\u03c9\u03bd \u03bc\u03b5\u03bb\u03b5\u03c4\u03ce\u03bd \u03c0\u03bf\u03c5 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03b8\u03b7\u03ba\u03b1\u03bd \u03c3\u03b5 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ac \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ac (\u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf Pfizer-BioNTech \u00a0BNT162b2 mRNA<sup>2<\/sup>, \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf Moderna \u2013\u0395\u03b8\u03bd\u03b9\u03ba\u03ac \u00a0\u0399\u03bd\u03c3\u03c4\u03b9\u03c4\u03bf\u03cd\u03c4\u03b1 \u03a5\u03b3\u03b5\u03af\u03b1\u03c2 \u0397\u03a0\u0391 [NIH] mRNA-1273<sup>3<\/sup>, \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf AstraZeneca\u2013Oxford ChAdOx1 nCov-19<sup>4<\/sup>, \u00a0\u03ba\u03b1\u03b9 \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf Gamaleya \u00a0GamCovidVac \u00a0[Sputnik V]<sup>5<\/sup>\u00a0\u00a0\u03ba\u03b1\u03b9 \u03c4\u03c1\u03b5\u03b9\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03bc\u03ad\u03c3\u03c9 \u03c4\u03c9\u03bd \u03b5\u03b3\u03b3\u03c1\u03ac\u03c6\u03c9\u03bd \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7\u03c2 \u03c4\u03b7\u03c2 \u0391\u03bc\u03b5\u03c1\u03b9\u03ba\u03b1\u03bd\u03b9\u03ba\u03ae\u03c2 \u03a5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1\u03c2 \u03a4\u03c1\u03bf\u03c6\u03af\u03bc\u03c9\u03bd \u03ba\u03b1\u03b9 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd \u00a0(FDA) (\u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 Pfizer-BioNTech<sup>6<\/sup>, \u00a0Moderna\u2013NIH<sup>7<\/sup> \u00a0\u03ba\u03b1\u03b9 Johnson &amp; Johnson [J&amp;j] Ad26.COV2.S)<sup>8<\/sup>. \u00a0\u0395\u03c0\u03b9\u03c0\u03bb\u03ad\u03bf\u03bd,\u00a0\u03b1\u03c0\u03bf\u03c3\u03c0\u03ac\u03c3\u03bc\u03b1\u03c4\u03b1 \u03c4\u03c9\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03ac\u03c4\u03c9\u03bd \u03b1\u03c5\u03c4\u03ce\u03bd \u03ba\u03bf\u03b9\u03bd\u03bf\u03c0\u03bf\u03b9\u03ae\u03b8\u03b7\u03ba\u03b1\u03bd \u00a0\u03b5\u03c5\u03c1\u03ad\u03c9\u03c2 \u03ba\u03b1\u03b9 \u03c3\u03c5\u03b6\u03b7\u03c4\u03ae\u03b8\u03b7\u03ba\u03b1\u03bd \u03bc\u03ad\u03c3\u03c9 \u03b4\u03b5\u03bb\u03c4\u03af\u03c9\u03bd \u03a4\u03cd\u03c0\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9\u03bd \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7\u03c2, \u03b5\u03bd\u03af\u03bf\u03c4\u03b5 \u03bc\u03b5 \u03c0\u03b1\u03c1\u03b1\u03c0\u03bb\u03b1\u03bd\u03b7\u03c4\u03b9\u03ba\u03bf\u03cd\u03c2 \u03c4\u03c1\u03cc\u03c0\u03bf\u03c5\u03c2<sup>9<\/sup>.\u00a0\u0391\u03bd \u03ba\u03b1\u03b9 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03bf\u03c7\u03ae \u03ad\u03c7\u03b5\u03b9 \u03b5\u03c0\u03b9\u03ba\u03b5\u03bd\u03c4\u03c1\u03c9\u03b8\u03b5\u03af \u03c3\u03c4\u03b7 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u00a0\u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03c4\u03b7 \u03c3\u03cd\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03af\u03c9\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 \u03b1\u03c1\u03b9\u03b8\u03bc\u03bf\u03cd \u03c3\u03c5\u03bc\u03c0\u03c4\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ce\u03bd \u00a0\u03c0\u03b5\u03c1\u03b9\u03c0\u03c4\u03ce\u03c3\u03b5\u03c9\u03bd, \u03b7 \u03c0\u03bb\u03ae\u03c1\u03b7\u03c2 \u00a0\u03ba\u03b1\u03c4\u03b1\u03bd\u03cc\u03b7\u03c3\u03b7 \u00a0\u03c4\u03b7\u03c2 \u00a0\u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03b5\u03af\u03bd\u03b1\u03b9 \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b1\u03c0\u03bb\u03ae \u03b1\u03c0\u03cc \u03cc, \u03c4\u03b9 \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c6\u03b1\u03af\u03bd\u03b5\u03c4\u03b1\u03b9. \u0391\u03bd\u03ac\u03bb\u03bf\u03b3\u03b1 \u03bc\u03b5 \u03c4\u03bf\u03bd \u03c4\u03c1\u03cc\u03c0\u03bf \u03ad\u03ba\u03c6\u03c1\u03b1\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 \u03bc\u03b5\u03b3\u03ad\u03b8\u03bf\u03c5\u03c2 \u03c4\u03bf\u03c5 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2, \u00a0\u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c0\u03c1\u03bf\u03ba\u03cd\u03c8\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03b5\u03bd\u03c4\u03b5\u03bb\u03ce\u03c2 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ae \u03b5\u03b9\u03ba\u03cc\u03bd\u03b1 \u00a0(\u03b3\u03c1\u03ac\u03c6\u03b7\u03bc\u03b1).<\/p>\n<p>\u0397 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03b1\u03bd\u03b1\u03c6\u03ad\u03c1\u03b5\u03c4\u03b1\u03b9 \u03b3\u03b5\u03bd\u03b9\u03ba\u03ac \u03c9\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ae \u03bc\u03b5\u03af\u03c9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 (<em>Relative Risk Reduction<\/em>: RRR). \u03a7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03b5\u03af\u03c4\u03b1\u03b9 \u03bf \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03cc\u03c2 \u00a0\u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf\u03c2 (RR)\u2014\u03b4\u03b7\u03bb\u03b1\u03b4\u03ae \u00a0\u03b7 \u00a0\u03b1\u03bd\u03b1\u03bb\u03bf\u03b3\u03af\u03b1 \u00a0\u03c4\u03c9\u03bd \u03c0\u03bf\u03c3\u03bf\u03c3\u03c4\u03ce\u03bd \u00a0\u03b5\u03c0\u03af\u03b8\u03b5\u03c3\u03b7\u03c2 \u00a0\u03bc\u03b5 \u00a0\u03ba\u03b1\u03b9 \u00a0\u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf \u2014 \u03bf \u03bf\u03c0\u03bf\u03af\u03bf\u03c2 \u00a0\u03b5\u03ba\u03c6\u03c1\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03c9\u03c2 1-RR. \u0397 \u03ba\u03b1\u03c4\u03ac\u03c4\u03b1\u03be\u03b7 \u03b2\u03ac\u03c3\u03b5\u03b9 \u03b1\u03bd\u03b1\u03c6\u03b5\u03c1\u03cc\u03bc\u03b5\u03bd\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03b4\u03af\u03bd\u03b5\u03b9 \u00a0\u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03b9\u03ce\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 \u03c4\u03b7\u03c2 \u03c4\u03ac\u03be\u03b7\u03c2 \u03c4\u03bf\u03c5 95% \u03b3\u03b9\u03b1 \u03c4\u03bf Pfizer-BioNTech, \u00a094% \u03b3\u03b9\u03b1 \u03c4\u03bf \u00a0Moderna-NIH, 90% \u03b3\u03b9\u03b1 \u03c4\u03bf \u00a0Gamaleya, \u00a067% \u03b3\u03b9\u03b1 \u03c4\u03bf J&amp;J \u03ba\u03b1\u03b9 67% \u03b3\u03b9\u03b1 \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf AstraZeneca-Oxford. \u00a0\u03a9\u03c3\u03c4\u03cc\u03c3\u03bf, \u03c4\u03bf RRR \u03b8\u03b1 \u03c0\u03c1\u03ad\u03c0\u03b5\u03b9 \u03bd\u03b1 \u03b1\u03bd\u03c4\u03b9\u03c0\u03b1\u03c1\u03b1\u03b2\u03ac\u03bb\u03bb\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03c6\u03cc\u03bd\u03c4\u03bf \u00a0\u03c4\u03bf\u03bd \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf \u03bc\u03cc\u03bb\u03c5\u03bd\u03c3\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c3\u03b8\u03ad\u03bd\u03b5\u03b9\u03b1\u03c2 \u00a0\u03b1\u03c0\u03cc \u00a0COVID-19, \u03bf \u03bf\u03c0\u03bf\u03af\u03bf\u03c2 \u00a0\u03c0\u03bf\u03b9\u03ba\u03af\u03bb\u03bb\u03b5\u03b9 \u00a0\u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03c4\u03c9\u03bd \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03ce\u03bd \u00a0\u03ba\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03c0\u03ac\u03c1\u03bf\u03b4\u03bf \u03c4\u03bf\u03c5 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c5. \u0391\u03bd \u03ba\u03b1\u03b9 \u03c4\u03bf RRR \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03b5\u03b9 \u03bc\u03cc\u03bd\u03bf \u03c4\u03bf\u03c5\u03c2 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 \u00a0\u03c0\u03bf\u03c5 \u03b8\u03b1 \u03bc\u03c0\u03bf\u03c1\u03bf\u03cd\u03c3\u03b1\u03bd \u03bd\u03b1 \u03b5\u03c0\u03c9\u03c6\u03b5\u03bb\u03b7\u03b8\u03bf\u03cd\u03bd \u03b1\u03c0\u03cc \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf, \u03b7 \u03b1\u03c0\u03cc\u03bb\u03c5\u03c4\u03b7 \u03bc\u03b5\u03af\u03c9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 (ARR), \u03b7 \u03bf\u03c0\u03bf\u03af\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b7 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03ac \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03c4\u03c9\u03bd \u03c0\u03bf\u03c3\u03bf\u03c3\u03c4\u03ce\u03bd \u03b5\u03c0\u03af\u03b8\u03b5\u03c3\u03b7\u03c2 \u03bc\u03b5 \u03ba\u03b1\u03b9 \u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf, \u03c3\u03c4\u03b1\u03b8\u03bc\u03af\u03b6\u03b5\u03b9 \u03bf\u03bb\u03cc\u03ba\u03bb\u03b7\u03c1\u03bf \u03c4\u03bf\u03bd \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03cc. \u03a4\u03b1 ARRs \u00a0\u03c4\u03b5\u03af\u03bd\u03bf\u03c5\u03bd \u03bd\u03b1 \u00a0\u03b1\u03b3\u03bd\u03bf\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b5\u03c0\u03b5\u03b9\u03b4\u03ae \u00a0\u03b4\u03af\u03bd\u03bf\u03c5\u03bd \u03c0\u03bf\u03bb\u03cd \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b5\u03bd\u03c4\u03c5\u03c0\u03c9\u03c3\u03b9\u03b1\u03ba\u03cc \u03bc\u03ad\u03b3\u03b5\u03b8\u03bf\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2 \u03b1\u03c0\u03cc \u03c4\u03b1 RRRs: 1,3% \u03b3\u03b9\u03b1 \u03c4\u03bf AstraZeneca-Oxford, 1,2% \u03b3\u03b9\u03b1 \u03c4\u03bf \u00a0Moderna-NIH, \u00a01,2% \u03b3\u03b9\u03b1 \u03c4\u03bf J&amp;J, 0,93% \u03b3\u03b9\u03b1 \u03c4\u03bf \u00a0Gamaleya \u03ba\u03b1\u03b9 0,84% \u03b3\u03b9\u03b1 \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf Pfizer\u2013BioNTech.<\/p>\n<p>\u03a4\u03bf ARR \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03b5\u03af\u03c4\u03b1\u03b9 \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03b1\u03bd\u03c4\u03bb\u03ae\u03c3\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03b5\u03ba\u03c4\u03af\u03bc\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5, \u00a0\u03b7 \u03bf\u03c0\u03bf\u03af\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03bf \u03b1\u03c1\u03b9\u03b8\u03bc\u03cc\u03c2 \u03c0\u03bf\u03c5 \u03b1\u03c0\u03b1\u03b9\u03c4\u03b5\u03af\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc\u00a0(NNV) \u00a0\u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7\u00a0\u03b5\u03bd\u03cc\u03c2 \u03b1\u03ba\u03cc\u03bc\u03b7 \u00a0\u03c0\u03b5\u03c1\u03b9\u03c3\u03c4\u03b1\u03c4\u03b9\u03ba\u03bf\u03cd\u00a0COVID-19 \u03c9\u03c2 1\/ARR.<br \/>\n\u03a4\u03b1 NNVs \u03c6\u03ad\u03c1\u03bd\u03bf\u03c5\u03bd \u03bc\u03b9\u03b1 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03bf\u03c0\u03c4\u03b9\u03ba\u03ae: 76 \u03b3\u03b9\u03b1 \u03c4\u03b7 Moderna\u2013NIH, 78 \u03b3\u03b9\u03b1 \u03c4\u03bf AstraZeneca-Oxford, 80 \u03b3\u03b9\u03b1 \u03c4\u03bf Gamaleya, 84 \u03b3\u03b9\u03b1 \u03c4\u03bf J&amp;j \u03ba\u03b1\u03b9 117 \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 Pfizer-BioNTech. \u0397 \u03b5\u03be\u03ae\u03b3\u03b7\u03c3\u03b7 \u03ad\u03b3\u03ba\u03b5\u03b9\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03c4\u03b7\u03c2 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03c5\u03c0\u03bf\u03b2\u03ac\u03b8\u03c1\u03c9\u03bd \u03b1\u03c5\u03be\u03b7\u03bc\u03ad\u03bd\u03bf\u03c5 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 COVID-19 \u03c3\u03b5 \u03cc\u03bb\u03b5\u03c2 \u03c4\u03b9\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2: 0,9% \u03b3\u03b9\u03b1 \u03c4\u03bf Pfizer\u2013BioNTech, 1% \u03b3\u03b9\u03b1 \u03c4\u03bf Gamaleya,1,4% \u03b3\u03b9\u03b1 \u03c4\u03bf \u00a0Moderna-NIH, 1,8% \u03b3\u03b9\u03b1 \u03c4\u03bf J&amp;J \u00a0\u03ba\u03b1\u03b9 \u00a01,9% \u00a0\u03b3\u03b9\u03b1 \u00a0\u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 AstraZeneca-Oxford.<\/p>\n<p>\u0397 ARR (\u03ba\u03b1\u03b9 \u03b7 NNV) \u03b5\u03af\u03bd\u03b1\u03b9 \u03b5\u03c5\u03b1\u03af\u03c3\u03b8\u03b7\u03c4\u03b5\u03c2 \u03c3\u03c4\u03bf\u03bd \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf \u03c5\u03c0\u03bf\u03b2\u03ac\u03b8\u03c1\u03bf\u03c5- <strong>\u03cc\u03c3\u03bf \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03bf\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03bf \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf\u03c2, \u03c4\u03cc\u03c3\u03bf \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1<\/strong> \u2013 \u03cc\u03c0\u03c9\u03c2 \u03c0\u03b1\u03c1\u03b1\u03b4\u03b5\u03b9\u03b3\u03bc\u03b1\u03c4\u03af\u03b6\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b9\u03c2 \u03b1\u03bd\u03b1\u03bb\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 J&amp;J \u03c3\u03b5 \u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ac \u03b5\u03c0\u03b9\u03b2\u03b5\u03b2\u03b1\u03b9\u03c9\u03bc\u03ad\u03bd\u03b1 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c4\u03b1\u03c4\u03b9\u03ba\u03ac \u03c3\u03c5\u03b3\u03ba\u03c1\u03b9\u03bd\u03cc\u03bc\u03b5\u03bd\u03b1 \u03cc\u03bb\u03b5\u03c2 \u03c4\u03b9\u03c2 \u03c0\u03b5\u03c1\u03b9\u03c0\u03c4\u03ce\u03c3\u03b5\u03b9\u03c2<sup>8<\/sup> :\u00a0 \u03b1\u03bc\u03c6\u03cc\u03c4\u03b5\u03c1\u03bf\u03b9 \u03bf\u00a0\u03b1\u03c1\u03b9\u03b8\u03bc\u03b7\u03c4\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03bf \u03c0\u03b1\u03c1\u03bf\u03bd\u03bf\u03bc\u03b1\u03c3\u03c4\u03ae\u03c2 \u03b1\u03bb\u03bb\u03ac\u03b6\u03bf\u03c5\u03bd, \u03c4\u03bf RRR \u03b4\u03b5\u03bd \u03b1\u03bb\u03bb\u03ac\u03b6\u03b5\u03b9 (66-67%), \u03b1\u03bb\u03bb\u03ac \u03c4\u03bf \u03ad\u03bd\u03b1 \u03c4\u03c1\u03af\u03c4\u03bf \u03c4\u03b7\u03c2 \u03b1\u03cd\u03be\u03b7\u03c3\u03b7\u03c2 \u03c4\u03c9\u03bd \u03c0\u03bf\u03c3\u03bf\u03c3\u03c4\u03ce\u03bd \u03b5\u03c0\u03af\u03b8\u03b5\u03c3\u03b7\u03c2 \u00a0\u03c3\u03c4\u03b7\u03bd \u03bf\u03bc\u03ac\u03b4\u03b1 \u03c0\u03bf\u03c5 \u03b4\u03b5\u03bd \u03ad\u03c7\u03b5\u03b9 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03b5\u03af (\u03b1\u03c0\u03cc 1,8% \u03ad\u03c9\u03c2 2,4%) \u03bc\u03b5\u03c4\u03b1\u03c6\u03c1\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03ad\u03bd\u03b1 \u03c4\u03ad\u03c4\u03b1\u03c1\u03c4\u03bf \u03bc\u03b5\u03af\u03c9\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 NNV (\u03b1\u03c0\u03cc 84 \u03c3\u03b5 64).<\/p>\n<figure class=\"wp-block-image\"><img decoding=\"async\" class=\"wp-image-3416\" src=\"https:\/\/eternalnowblog.files.wordpress.com\/2021\/05\/screenshot_1-1.png?w=529\" alt=\"\" \/><figcaption><em>\u0393\u03c1\u03ac\u03c6\u03b7\u03bc\u03b1:<\/em> RRR \u03ba\u03b1\u03b9 NNV \u03bc\u03b5 95% CI \u03c4\u03b1\u03be\u03b9\u03bd\u03bf\u03bc\u03b7\u03bc\u03ad\u03bd\u03bf \u03b2\u03ac\u03c3\u03b5\u03b9 \u03c0\u03bf\u03c3\u03bf\u03c3\u03c4\u03bf\u03cd \u03b5\u03c0\u03af\u03b8\u03b5\u03c3\u03b7\u03c2 \u03c3\u03c4\u03b7\u03bd \u03bf\u03bc\u03ac\u03b4\u03b1 \u00a0\u03b1\u03bd\u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03b1\u03c3\u03c4\u03c9\u03bd \u00a0(\u03b5\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03cc \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf: placebo) \u00a0\u03b3\u03b9\u03b1 \u03c0\u03ad\u03bd\u03c4\u03b5 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 COVID-19<br \/>\n\u038c\u03c3\u03bf \u03c7\u03b1\u03bc\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03bf \u03b5\u03af\u03bd\u03b1\u03b9 \u03c4\u03bf NNV \u03ba\u03b1\u03b9 \u03cc\u03c3\u03bf \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03bf \u03b5\u03af\u03bd\u03b1\u03b9 \u03c4\u03bf RRR, \u03c4\u03cc\u03c3\u03bf \u03ba\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b7 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5. \u039b\u03b5\u03c0\u03c4\u03bf\u03bc\u03ad\u03c1\u03b5\u03b9\u03b5\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u00a0\u03c3\u03c4\u03bf \u03c0\u03c1\u03bf\u03c3\u03ac\u03c1\u03c4\u03b7\u03bc\u03b1.<br \/>\nRRR=\u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ae \u03bc\u03b5\u03af\u03c9\u03c3\u03b7 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5. \u00a0\u00a0NNV=\u03b1\u03c1\u03b9\u03b8\u03bc\u03bf\u03af \u03c0\u03bf\u03c5 \u03b1\u03c0\u03b1\u03b9\u03c4\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc. \u00a0NIH=\u0395\u03b8\u03bd\u03b9\u03ba\u03ac \u0399\u03bd\u03c3\u03c4\u03b9\u03c4\u03bf\u03cd\u03c4\u03b1 \u03a5\u03b3\u03b5\u03af\u03b1\u03c2 \u03c4\u03c9\u03bd \u00a0\u0397\u03a0\u0391.<\/figcaption><\/figure>\n<p>\u03a5\u03c0\u03ac\u03c1\u03c7\u03bf\u03c5\u03bd \u03c0\u03bf\u03bb\u03bb\u03ac \u03b4\u03b9\u03b4\u03ac\u03b3\u03bc\u03b1\u03c4\u03b1 \u03c0\u03c1\u03bf\u03c2 \u03b5\u03ba\u03bc\u03ac\u03b8\u03b7\u03c3\u03b7 \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd \u03c4\u03c1\u03cc\u03c0\u03bf \u03b4\u03b9\u03b5\u03be\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u03c4\u03c9\u03bd \u03bc\u03b5\u03bb\u03b5\u03c4\u03ce\u03bd \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03bf\u03c5\u03c3\u03af\u03b1\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03ac\u03c4\u03c9\u03bd. \u039c\u03b5 \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u03bc\u03cc\u03bd\u03bf \u03c4\u03c9\u03bd RRRs \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03ac\u03bb\u03b5\u03b9\u03c8\u03b7 \u03c4\u03c9\u03bd ARRs, \u03b5\u03b9\u03c3\u03ac\u03b3\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5\u03c1\u03bf\u03bb\u03b7\u03c8\u03af\u03b1 \u03b1\u03bd\u03b1\u03c6\u03bf\u03c1\u03ac\u03c2, \u03b7 \u03bf\u03c0\u03bf\u03af\u03b1 \u03b5\u03c0\u03b7\u03c1\u03b5\u03ac\u03b6\u03b5\u03b9 \u03c4\u03b7\u03bd \u03b5\u03c1\u03bc\u03b7\u03bd\u03b5\u03af\u03b1 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5<sup>10<\/sup>. \u00a0\u00a0\u039a\u03b1\u03c4\u03ac \u03c4\u03b7\u03bd \u03b5\u03c0\u03b9\u03ba\u03bf\u03b9\u03bd\u03c9\u03bd\u03af\u03b1 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5, \u03b5\u03b9\u03b4\u03b9\u03ba\u03ac \u00a0\u03b3\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c6\u03ac\u03c3\u03b5\u03b9\u03c2 \u03b4\u03b7\u03bc\u03cc\u03c3\u03b9\u03b1\u03c2 \u03c5\u03b3\u03b5\u03af\u03b1\u03c2, \u03cc\u03c0\u03c9\u03c2 \u03b7 \u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03c4\u03bf\u03c5 \u03c4\u03cd\u03c0\u03bf\u03c5 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03b3\u03b9\u03b1 \u03b1\u03b3\u03bf\u03c1\u03ac \u03ba\u03b1\u03b9 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7, \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ae \u00a0\u03b7 \u03c0\u03bb\u03ae\u03c1\u03b7\u03c2 \u03b5\u03b9\u03ba\u03cc\u03bd\u03b1 \u03c4\u03bf\u03c5 \u03c4\u03b9 \u03c0\u03c1\u03b1\u03b3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03b4\u03b5\u03af\u03c7\u03bd\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1, \u03ba\u03b1\u03b8\u03ce\u03c2 \u03ba\u03b1\u03b9 \u03b7 \u03b4\u03b9\u03b1\u03c3\u03c6\u03ac\u03bb\u03b9\u03c3\u03b7 \u03cc\u03c4\u03b9 \u03bf\u03b9 \u03c3\u03c5\u03b3\u03ba\u03c1\u03af\u03c3\u03b5\u03b9\u03c2 \u03b2\u03b1\u03c3\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b1 \u00a0\u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03ad\u03bd\u03b1 \u03c3\u03c4\u03bf\u03b9\u03c7\u03b5\u03af\u03b1 \u03c0\u03bf\u03c5 \u03b8\u03ad\u03c4\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03b1 \u03c4\u03c9\u03bd \u03b4\u03bf\u03ba\u03b9\u03bc\u03ce\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03b5\u03bd\u03c4\u03cc\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03c5\u03c1\u03cd\u03c4\u03b5\u03c1\u03bf\u03c5 \u03c0\u03bb\u03b1\u03b9\u03c3\u03af\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03bd \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03bc\u03cc\u03bd\u03bf \u03ad\u03bd\u03b1 \u03c3\u03c5\u03bd\u03bf\u03c0\u03c4\u03b9\u03ba\u03cc \u03bc\u03ad\u03c4\u03c1\u03bf. \u00a0\u03a4\u03ad\u03c4\u03bf\u03b9\u03b5\u03c2 \u03b1\u03c0\u03bf\u03c6\u03ac\u03c3\u03b5\u03b9\u03c2 \u03b8\u03b1 \u03c0\u03c1\u03ad\u03c0\u03b5\u03b9 \u03bd\u03b1 \u03b5\u03bd\u03b7\u03bc\u03b5\u03c1\u03ce\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03cc\u03bd\u03c4\u03c9\u03c2 \u03bc\u03b5 \u03bb\u03b5\u03c0\u03c4\u03bf\u03bc\u03b5\u03c1\u03ae \u00a0\u03ba\u03b1\u03c4\u03b1\u03bd\u03cc\u03b7\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03ac\u03c4\u03c9\u03bd \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2, \u03b1\u03c0\u03b1\u03b9\u03c4\u03ce\u03bd\u03c4\u03b1\u03c2 \u03c0\u03c1\u03cc\u03c3\u03b2\u03b1\u03c3\u03b7 \u03c3\u03b5 \u03c0\u03bb\u03ae\u03c1\u03b7 \u03c3\u03cd\u03bd\u03bf\u03bb\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd \u03ba\u03b1\u03b9 \u03b1\u03bd\u03b5\u03be\u03ac\u03c1\u03c4\u03b7\u03c4\u03b7 \u03b4\u03b9\u03b5\u03c1\u03b5\u03cd\u03bd\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7.<\/p>\n<p>\u0394\u03c5\u03c3\u03c4\u03c5\u03c7\u03ce\u03c2, \u03b7 \u03c3\u03cd\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03bc\u03b5 \u03b2\u03ac\u03c3\u03b7 \u03c4\u03b1 \u03b4\u03b9\u03b1\u03b8\u03ad\u03c3\u03b9\u03bc\u03b1 \u03b5\u03c0\u03af \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03cc\u03bd\u03c4\u03bf\u03c2 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ce\u03bd (\u03b5\u03bd\u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03bf \u03c3\u03c4\u03ac\u03b4\u03b9\u03bf) \u03b3\u03af\u03bd\u03b5\u03c4\u03b1\u03b9 \u03b1\u03ba\u03cc\u03bc\u03b7 \u03c0\u03b9\u03bf \u03b4\u03cd\u03c3\u03ba\u03bf\u03bb\u03b7 \u03bc\u03b5 \u03b1\u03bd\u03cc\u03bc\u03bf\u03b9\u03b1 \u03c0\u03c1\u03c9\u03c4\u03cc\u03ba\u03bf\u03bb\u03bb\u03b1 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2, \u03c3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03b1\u03bd\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd \u03c4\u03c9\u03bd \u03ba\u03cd\u03c1\u03b9\u03c9\u03bd \u03c4\u03b5\u03bb\u03b9\u03ba\u03ce\u03bd \u03c3\u03b7\u03bc\u03b5\u03af\u03c9\u03bd (\u03cc\u03c0\u03c9\u03c2 \u03c4\u03bf \u03c4\u03b9 \u03b8\u03b5\u03c9\u03c1\u03b5\u03af\u03c4\u03b1\u03b9 \u03ba\u03c1\u03bf\u03cd\u03c3\u03bc\u03b1 COVID-19 \u03ba\u03b1\u03b9 \u03c0\u03cc\u03c4\u03b5 \u03b1\u03c5\u03c4\u03cc \u03b1\u03be\u03b9\u03bf\u03bb\u03bf\u03b3\u03b5\u03af\u03c4\u03b1\u03b9), \u03c4\u03c9\u03bd \u03c4\u03cd\u03c0\u03c9\u03bd \u00a0\u03b5\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03bf\u03cd \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 (placebo), \u03c4\u03b7\u03c2 \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03b9\u03b1\u03ba\u03ae\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2, \u03c4\u03c9\u03bd \u03c5\u03c0\u03bf\u03b2\u03ac\u03b8\u03c1\u03c9\u03bd \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03c9\u03bd COVID-19 \u00a0\u03ba\u03b1\u03c4\u03ac \u03c4\u03b7 \u03b4\u03b9\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2, \u03c4\u03b7\u03c2 \u03b4\u03b9\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03ad\u03ba\u03b8\u03b5\u03c3\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03bf\u03c1\u03b9\u03c3\u03bc\u03ce\u03bd \u03c4\u03c9\u03bd \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03ce\u03bd \u03b3\u03b9\u03b1 \u03b1\u03bd\u03b1\u03bb\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c4\u03cc\u03c3\u03bf \u03b5\u03bd\u03c4\u03cc\u03c2 \u03cc\u03c3\u03bf \u03ba\u03b1\u03b9 \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03bc\u03b5\u03bb\u03b5\u03c4\u03ce\u03bd, \u03ba\u03b1\u03b8\u03ce\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u03bf\u03c1\u03b9\u03c3\u03bc\u03ce\u03bd \u03c4\u03c9\u03bd \u03c0\u03b1\u03c1\u03b1\u03bc\u03ad\u03c4\u03c1\u03c9\u03bd \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u03c3\u03c4\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03bc\u03b5\u03b8\u03cc\u03b4\u03c9\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2. \u0395\u03af\u03bd\u03b1\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc \u03cc\u03c4\u03b9 \u03bc\u03b1\u03c2 \u03bc\u03ad\u03bd\u03b5\u03b9 \u03c4\u03bf \u03b1\u03bd\u03b1\u03c0\u03ac\u03bd\u03c4\u03b7\u03c4\u03bf \u03b5\u03c1\u03ce\u03c4\u03b7\u03bc\u03b1 \u03b5\u03ac\u03bd \u03ad\u03bd\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf \u03bc\u03b5 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b7 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c3\u03b5 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c3\u03c5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03bf\u03c5 \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03bf\u03cd \u03b8\u03b1 \u03ad\u03c7\u03b5\u03b9 \u03c4\u03b7\u03bd \u03af\u03b4\u03b9\u03b1 \u00a0\u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c3\u03b5 \u03ad\u03bd\u03b1\u03bd \u03ac\u03bb\u03bb\u03bf \u03c0\u03bb\u03b7\u03b8\u03c5\u03c3\u03bc\u03cc \u03bc\u03b5 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ac \u03b5\u03c0\u03af\u03c0\u03b5\u03b4\u03b1 \u03c5\u03c0\u03bf\u03b2\u03ac\u03b8\u03c1\u03bf\u03c5 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 COVID-19. \u0394\u03b5\u03bd \u03c0\u03c1\u03cc\u03ba\u03b5\u03b9\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03b1\u03c3\u03ae\u03bc\u03b1\u03bd\u03c4\u03bf \u03b5\u03c1\u03ce\u03c4\u03b7\u03bc\u03b1, \u03b4\u03b9\u03cc\u03c4\u03b9 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03c3\u03b7 \u03bc\u03b5\u03c4\u03ac\u03b4\u03bf\u03c3\u03b7\u03c2 \u03c0\u03bf\u03b9\u03ba\u03af\u03bb\u03bb\u03b5\u03b9 \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03c4\u03c9\u03bd \u03c7\u03c9\u03c1\u03ce\u03bd, \u03ba\u03b1\u03b9 \u03b5\u03c0\u03b7\u03c1\u03b5\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u00a0\u03b1\u03c0\u03cc \u03c0\u03b1\u03c1\u03ac\u03b3\u03bf\u03bd\u03c4\u03b5\u03c2 \u03cc\u03c0\u03c9\u03c2 \u03bf\u03b9 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03ac\u03c3\u03b5\u03b9\u03c2 \u03b4\u03b7\u03bc\u03cc\u03c3\u03b9\u03b1\u03c2 \u03c5\u03b3\u03b5\u03af\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03bf\u03b9 \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ad\u03c2 \u03c4\u03bf\u03c5 \u03b9\u03bf\u03cd. \u0397 \u03bc\u03cc\u03bd\u03b7 \u03ba\u03b1\u03c4\u03b1\u03b3\u03b5\u03b3\u03c1\u03b1\u03bc\u03bc\u03ad\u03bd\u03b7 \u03ad\u03bd\u03b4\u03b5\u03b9\u03be\u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b7 \u03b9\u03c3\u03c1\u03b1\u03b7\u03bb\u03b9\u03bd\u03ae \u03b5\u03ba\u03c3\u03c4\u03c1\u03b1\u03c4\u03b5\u03af\u03b1 \u03bc\u03b1\u03b6\u03b9\u03ba\u03bf\u03cd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd \u03bc\u03b5 \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03bf\u03c2 Pfizer-BioNTech. \u00a0\u0391\u03bd \u03ba\u03b1\u03b9 \u03bf \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03bc\u03cc\u03c2 \u03ba\u03b1\u03b9 \u03b7 \u03bc\u03b5\u03b8\u03bf\u03b4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c1\u03b9\u03b6\u03b9\u03ba\u03ac \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03bf\u03af \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7 \u00a0\u03b4\u03bf\u03ba\u03b9\u03bc\u03ae<sup>2<\/sup>, \u03bf Dagan \u03ba\u03b1\u03b9 \u03bf\u03b9 \u03c3\u03c5\u03bd\u03ac\u03b4\u03b5\u03bb\u03c6\u03bf\u03af \u03c4\u03bf\u03c5<sup>11<\/sup> \u00a0\u03b1\u03bd\u03b1\u03c6\u03ad\u03c1\u03bf\u03c5\u03bd \u03ad\u03bd\u03b1 \u00a0RRR 94%, \u03c4\u03bf \u03bf\u03c0\u03bf\u03af\u03bf \u03b5\u03af\u03bd\u03b1\u03b9 \u03bf\u03c5\u03c3\u03b9\u03b1\u03c3\u03c4\u03b9\u03ba\u03ac \u03c4\u03bf \u03af\u03b4\u03b9\u03bf \u03bc\u03b5 \u03c4\u03bf RRR \u03c4\u03b7\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ae\u03c2 \u03c6\u03ac\u03c3\u03b7\u03c2 3 \u00a0(95%), \u03b1\u03bb\u03bb\u03ac \u03bc\u03b5 ARR \u00a00,46%, \u03c4\u03bf \u03bf\u03c0\u03bf\u03af\u03bf \u03bc\u03b5\u03c4\u03b1\u03c6\u03c1\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03ad\u03bd\u03b1 NNV \u00a0217 \u00a0(\u03cc\u03c4\u03b1\u03bd \u03c4\u03bf ARR \u03ae\u03c4\u03b1\u03bd 0,84% \u03ba\u03b1\u03b9 \u03c4\u03bf NNV \u03ae\u03c4\u03b1\u03bd 119 \u03c3\u03c4\u03b7 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ae \u03c6\u03ac\u03c3\u03b7\u03c2 3). \u00a0\u00a0\u0391\u03c5\u03c4\u03cc \u03c3\u03b7\u03bc\u03b1\u03af\u03bd\u03b5\u03b9 \u03cc\u03c4\u03b9 \u03c3\u03b5 \u03ad\u03bd\u03b1 \u00a0\u03c0\u03c1\u03b1\u03b3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc \u03c0\u03b5\u03c1\u03b9\u03b2\u03ac\u03bb\u03bb\u03bf\u03bd, 1,8 \u00a0\u03c6\u03bf\u03c1\u03ad\u03c2 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b1 \u03ac\u03c4\u03bf\u03bc\u03b1 \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c7\u03c1\u03b5\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03bd\u03b1 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03bf\u03cd\u03bd \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03b1\u03c0\u03bf\u03c6\u03b5\u03c5\u03c7\u03b8\u03b5\u03af \u03ad\u03bd\u03b1 \u03b1\u03ba\u03cc\u03bc\u03b7 \u03ba\u03c1\u03bf\u03cd\u03c3\u03bc\u03b1 COVID-19 \u03b1\u03c0\u03cc \u03cc\u03c3\u03b1 \u00a0\u03c0\u03c1\u03bf\u03b2\u03bb\u03ad\u03c0\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03b1\u03bd\u03c4\u03af\u03c3\u03c4\u03bf\u03b9\u03c7\u03b7\u00a0\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u00a0\u03b4\u03bf\u03ba\u03b9\u03bc\u03ae.<\/p>\n<p>\u039f\u03b9 \u03b1\u03c3\u03c5\u03bd\u03c4\u03cc\u03bd\u03b9\u03c3\u03c4\u03b5\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c6\u03ac\u03c3\u03b7\u03c2 3 \u03b4\u03b5\u03bd \u03b9\u03ba\u03b1\u03bd\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd \u03c4\u03b9\u03c2 \u03b1\u03c0\u03b1\u03b9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03b4\u03b7\u03bc\u03cc\u03c3\u03b9\u03b1\u03c2 \u03c5\u03b3\u03b5\u03af\u03b1\u03c2\u00b7 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bb\u03b1\u03c4\u03c6\u03cc\u03c1\u03bc\u03b1\u03c2 \u00a0\u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03bd\u03c4\u03b9\u03bc\u03b5\u03c4\u03ce\u03c0\u03b9\u03c3\u03b7 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03b8\u03b5\u03bc\u03ac\u03c4\u03c9\u03bd \u03b4\u03b7\u03bc\u03cc\u03c3\u03b9\u03b1\u03c2 \u03c5\u03b3\u03b5\u03af\u03b1\u03c2 \u03bc\u03b5 \u03ba\u03bf\u03b9\u03bd\u03cc \u03c0\u03c1\u03c9\u03c4\u03cc\u03ba\u03bf\u03bb\u03bb\u03bf, \u03b8\u03b1 \u03b5\u03c0\u03b9\u03c4\u03c1\u03ad\u03c0\u03bf\u03c5\u03bd \u03c4\u03b7 \u03bb\u03ae\u03c8\u03b7 \u03b1\u03c0\u03bf\u03c6\u03ac\u03c3\u03b5\u03c9\u03bd \u03b5\u03bd\u03b7\u03bc\u03b5\u03c1\u03c9\u03bc\u03ad\u03bd\u03c9\u03bd \u03bc\u03b5 \u03ba\u03bf\u03b9\u03bd\u03ac \u03ba\u03c1\u03b9\u03c4\u03ae\u03c1\u03b9\u03b1 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03b9\u03b1\u03af\u03b1 \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7. \u0391\u03c5\u03c4\u03ad\u03c2 \u03bf\u03b9 \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03b2\u03b1\u03c3\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03bc\u03ad\u03c4\u03c1\u03b7\u03c3\u03b7\u03c2 \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7\u03c2 \u03ae\u03c0\u03b9\u03b1\u03c2 \u03ad\u03c9\u03c2 \u03bc\u03ad\u03c4\u03c1\u03b9\u03b1\u03c2 \u03bb\u03bf\u03af\u03bc\u03c9\u03be\u03b7\u03c2 COVID-19\u00b7 \u00a0\u03b4\u03b5 \u03c3\u03c7\u03b5\u03b4\u03b9\u03ac\u03c3\u03c4\u03b7\u03ba\u03b1\u03bd \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03ba\u03b1\u03c4\u03b1\u03bb\u03ae\u03be\u03bf\u03c5\u03bd \u03c3\u03b5 \u03c3\u03c5\u03bc\u03c0\u03ad\u03c1\u03b1\u03c3\u03bc\u03b1 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7 \u03c4\u03b7\u03c2 \u03bd\u03bf\u03c3\u03b7\u03bb\u03b5\u03af\u03b1\u03c2, \u03c4\u03b7\u03c2 \u03c3\u03bf\u03b2\u03b1\u03c1\u03ae\u03c2 \u03bd\u03cc\u03c3\u03bf\u03c5 \u03ae \u03c4\u03bf\u03c5 \u03b8\u03b1\u03bd\u03ac\u03c4\u03bf\u03c5, \u03ae \u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7 \u03c4\u03bf\u03c5 \u03b4\u03c5\u03bd\u03b1\u03bc\u03b9\u03ba\u03bf\u03cd \u03bb\u03bf\u03af\u03bc\u03c9\u03be\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03bc\u03b5\u03c4\u03ac\u03b4\u03bf\u03c3\u03b7\u03c2. \u00a0\u0397 \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03ba\u03b1\u03c4\u03b1\u03bb\u03bb\u03b7\u03bb\u03cc\u03bb\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03c0\u03c1\u03ad\u03c0\u03b5\u03b9 \u03bd\u03b1 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03c5\u03c0\u03cc\u03c8\u03b7 \u03cc\u03bb\u03bf\u03c5\u03c2 \u03c4\u03bf\u03c5\u03c2 \u03b4\u03b5\u03af\u03ba\u03c4\u03b5\u03c2 \u03ba\u03b1\u03b9 \u03bd\u03b1 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03c4\u03b7\u03bd \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1, \u03c4\u03b7 \u03b4\u03c5\u03bd\u03b1\u03c4\u03cc\u03c4\u03b7\u03c4\u03b1 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b1\u03b8\u03b5\u03c3\u03b9\u03bc\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03bf \u03ba\u03cc\u03c3\u03c4\u03bf\u03c2.<\/p>\n<p><em>\u0394\u03b5\u03bd \u03b4\u03b7\u03bb\u03ce\u03bd\u03bf\u03c5\u03bc\u03b5 \u03b1\u03bd\u03c4\u03b1\u03b3\u03c9\u03bd\u03b9\u03c3\u03c4\u03b9\u03ba\u03ac \u03c3\u03c5\u03bc\u03c6\u03ad\u03c1\u03bf\u03bd\u03c4\u03b1.<\/em><br \/>\n<em>\u03a0\u03bd\u03b5\u03c5\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03b4\u03b9\u03ba\u03b1\u03b9\u03ce\u03bc\u03b1\u03c4\u03b1 \u00a9 2021 \u00a0\u039f(\u03bf\u03b9) \u00a0\u03c3\u03c5\u03b3\u03b3\u03c1\u03b1\u03c6\u03ad\u03b1\u03c2(-\u03bf\u03af). \u0394\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03cd\u03c4\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc \u00a0Elsevier \u00a0\u0395.\u03a0.\u0395.<br \/>\n\u0391\u03c5\u03c4\u03cc \u03b5\u03af\u03bd\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03ac\u03c1\u03b8\u03c1\u03bf \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae\u03c2 \u03c0\u03c1\u03cc\u03c3\u03b2\u03b1\u03c3\u03b7\u03c2 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03ac\u03b4\u03b5\u03b9\u03b1 CC \u00a0BY-NC-ND \u00a04.0. \u00a0<\/em><\/p>\n<p><strong><em>*\u03a0\u03b9\u03ad\u03c1\u03bf \u039f\u03bb\u03b9\u03ac\u03c1\u03bf,<\/em> <em>\u0395\u03bb\u03c2<\/em> <em>\u03a4\u03bf\u03c1\u03b5\u03ad\u03bb\u03b5,<\/em> <em>\u039c\u03b9\u03c3\u03ad\u03bb<\/em> <em>\u0392\u03b1\u03b9\u03bb\u03ac\u03bd\u03c4<\/em><\/strong><br \/>\n<a href=\"mailto:piero.olliaro@ndm.ox.ac.uk\"><strong>piero.olliaro@ndm.ox.ac.uk<\/strong><\/a><\/p>\n<p><em>\u039a\u03ad\u03bd\u03c4\u03c1\u03bf \u03a4\u03c1\u03bf\u03c0\u03b9\u03ba\u03ae\u03c2 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1\u03c2 \u03a5\u03b3\u03b5\u03af\u03b1\u03c2, \u03a4\u03bc\u03ae\u03bc\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u03c4\u03bf\u03c5 Nuffield, \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 OX3 7FZ, \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf (PO)\u00b7 \u0399\u03bd\u03c3\u03c4\u03b9\u03c4\u03bf\u03cd\u03c4\u03bf \u039a\u03b1\u03b9\u03bd\u03bf\u03c4\u03bf\u03bc\u03af\u03b1\u03c2 \u03ba\u03b1\u03b9 \u00a0\u0394\u03b7\u03bc\u03cc\u03c3\u03b9\u03bf\u03c5 \u03a3\u03ba\u03bf\u03c0\u03bf\u03cd, University College London, \u039b\u03bf\u03bd\u03b4\u03af\u03bd\u03bf, \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf (ET)\u00b7 \u039a\u03ad\u03bd\u03c4\u03c1\u03bf \u0399\u03ba\u03b1\u03bd\u03bf\u03c4\u03ae\u03c4\u03c9\u03bd \u00a0\u03b3\u03b9\u03b1 \u03c4\u03b7 \u039c\u03b5\u03b8\u03bf\u03b4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03ba\u03b1\u03b9\u03c4\u03b7\u03a3\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae, \u0399\u03bd\u03c3\u03c4\u03b9\u03c4\u03bf\u03cd\u03c4\u03bf \u03a5\u03b3\u03b5\u03af\u03b1\u03c2 \u03c4\u03bf\u03c5 \u039b\u03bf\u03c5\u03be\u03b5\u03bc\u03b2\u03bf\u03cd\u03c1\u03b3\u03bf\u03c5, Strassen, \u039b\u03bf\u03c5\u03be\u03b5\u03bc\u03b2\u03bf\u03cd\u03c1\u03b3\u03bf \u00a0(MV)<\/em><\/p>\n<ol>\n<li>Zimmer C, Corum J, Wee S-L. Covid-19 Vaccine Tracker. <a href=\"http:\/\/www\/\">https:\/\/www<\/a>. nytimes.com\/interactive\/2020\/science\/coronavirus-vaccine-tracker.html (accessed March 10, 2021).<\/li>\n<li>Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine. <em>N Engl J Med <\/em>2020; <strong>383: <\/strong>2603\u201315.<\/li>\n<li>Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. <em>N Engl J Med <\/em>2021; <strong>384: <\/strong>403\u201316.<\/li>\n<li>Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <em>Lancet <\/em>2021; <strong>397: <\/strong>99\u2013111.<\/li>\n<li>Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. <em>Lancet <\/em>2021; <strong>397: <\/strong>671\u201381.<\/li>\n<li>US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document. Dec 10, 2020. <a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">https:\/\/www<\/a>.fda.go<a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">v\/advisory-committees\/advisory-committee-calendar\/<\/a> vaccines-and-related-biological-products-advisory-committee-december- 10-2020-meeting-announcement (accessed March 10, 2021).<\/li>\n<li>US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document. Dec 17, 2020. <a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">https:\/\/www<\/a>.fda.go<a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">v\/advisory-committees\/advisory-committee-calendar\/<\/a> vaccines-and-related-biological-products-advisory-committee-december- 17-2020-meeting-announcement (accessed March 10, 2021).<\/li>\n<li>US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document. Feb 26, 2021. <a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">https:\/\/www<\/a>.fda.go<a href=\"http:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/\">v\/advisory-committees\/advisory-committee-calendar\/<\/a> vaccines-and-related-biological-products-advisory-committee-february- 26-2021-meeting-announcement (accessed March 10, 2021).<\/li>\n<li>Olliaro P. What does 95% COVID-19 vaccine efficacy really mean? <em>Lancet Infect Dis <\/em>2021; published online Feb 17. <a href=\"https:\/\/doi.org\/10.1016\/\">https:\/\/doi.org\/10.1016\/<\/a> S1473-3099(21)00075-X.<\/li>\n<li>Brown RB. Outcome reporting bias in COVID-19 mRNA vaccine clinical trials. <em>Medicina (Kaunas) <\/em>2021; <strong>57: <\/strong>199.<\/li>\n<li>Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. <em>N Engl J Med <\/em>2021; published online Feb 24. <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa2101765\">https:\/\/doi.org\/10.1056\/NEJMoa2101765<\/a>.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/eternalnowblog.com\/2021\/05\/31\/%ce%bc%ce%b5%ce%bb%ce%ad%cf%84%ce%b7-%ce%b4%cf%81%ce%b1%cf%83%cf%84%ce%b9%ce%ba%cf%8c%cf%84%ce%b7%cf%84%ce%b1%cf%82-%ce%ba%ce%b1%ce%b9-%ce%b1%cf%80%ce%bf%cf%84%ce%b5%ce%bb%ce%b5%cf%83%ce%bc%ce%b1\/\">\u03a0\u0397\u0393\u0397http:\/\/nikosxeiladakis.gr\/%ce%bc%ce%b5%ce%bb%ce%ad%cf%84%ce%b7-%ce%b4%cf%81%ce%b1%cf%83%cf%84%ce%b9%ce%ba%cf%8c%cf%84%ce%b7%cf%84%ce%b1%cf%82-%ce%ba%ce%b1%ce%b9-%ce%b1%cf%80%ce%bf%cf%84%ce%b5%ce%bb%ce%b5%cf%83%ce%bc%ce%b1\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.nikosxeiladakis.gr\">www.nikosxeiladakis.gr<\/a><\/p>\n<\/div>\n<div class=\"adL\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c3\u03c4\u03bf THE LANCET \u03c4\u03b7\u03c2 \u0394\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5\u03c2\u00a0 \u03ba\u03b1\u03b9 \u03b4\u03ae\u03b8\u03b5\u03bd \u0391\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u0395\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd Covid-19 \u039d\u03af\u03ba\u03bf\u03c2 \u03a7\u03b5\u03b9\u03bb\u03b1\u03b4\u03ac\u03ba\u03b7\u03c2 \u00b7 31 \u039c\u03b1\u0390\u03bf\u03c5 2021 &#8230;.\u0388\u03bd\u03b1 \u03b1\u03c0\u03cc \u03c4\u03b1 \u03c0\u03bb\u03ad\u03bf\u03bd \u03b4\u03b9\u03ac\u03c3\u03b7\u03bc\u03b1 \u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ac \u03c0\u03b5\u03c1\u03b9\u03bf\u03b4\u03b9\u03ba\u03ac \u03c3\u03c4\u03bf\u03bd \u03ba\u03cc\u03c3\u03bc\u03bf, \u03c4\u03bf The Lancet, \u03b4\u03b7\u03bc\u03bf\u03c3\u03af\u03b5\u03c5\u03c3\u03b5 \u03bc\u03b9\u03b1 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c0\u03bf\u03c5 \u03b4\u03b5\u03af\u03c7\u03bd\u03b5\u03b9 \u03cc\u03c4\u03b9 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 COVID-19 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ac \u03bc\u03cc\u03bd\u03bf \u03c3\u03c4\u03bf 0,84%, \u03b4\u03b7\u03bb\u03b1\u03b4\u03ae \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf 1%, \u03ba\u03b1\u03b9 \u03b4\u03b5\u03bd \u03b1\u03bd\u03c4\u03b1\u03c0\u03bf\u03ba\u03c1\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03b4\u03b7\u03bb\u03c9\u03b8\u03b5\u03af\u03c3\u03b1 &hellip; <\/p>\n<p><a class=\"more-link btn\" href=\"https:\/\/evaggelatos.com\/?p=20856\">\u03a3\u03c5\u03bd\u03ad\u03c7\u03b5\u03b9\u03b1 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68],"tags":[196,217,62,122,244,106],"class_list":["post-20856","post","type-post","status-publish","format-standard","hentry","category-68","tag-196","tag-217","tag-62","tag-122","tag-244","tag-106","item-wrap"],"_links":{"self":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/20856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20856"}],"version-history":[{"count":4,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/20856\/revisions"}],"predecessor-version":[{"id":20860,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/20856\/revisions\/20860"}],"wp:attachment":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}